InvestorsHub Logo

kiy

Followers 53
Posts 16175
Boards Moderated 3
Alias Born 08/19/2010

kiy

Re: None

Thursday, 09/07/2017 11:22:57 PM

Thursday, September 07, 2017 11:22:57 PM

Post# of 426
EYES(T/$5) bionic eye...WE Are Borg...you will be assimilated...

08/21/2017...Elon Musk and AI experts urge U.N. to ban artificial intelligence in weapons.
Earlier this year, Elon Musk unveiled details about his new venture Neuralink[color=red][/color], a California company that plans to develop a device that can be implanted into the brain and help people who have certain brain injuries, such as strokes. The device would enable a person’s brain to connect wirelessly with the cloud, as well as with computers and with other brains that have the implant.

The end goal of the device, Musk said, is to fight potentially dangerous applications of artificial intelligence.

“We’re going to have the choice of either being left behind and being effectively useless or like a pet — you know, like a house cat or something — or eventually figuring out some way to be symbiotic and merge with AI,” Musk said in a story on the website Wait But Why.

Wall Street Daily 09/07/2017
Neuralink Corp. is a Musk-backed tech startup pursuing what he calls "neural lace" technology.
Put simply, we're talking about computers inside the brain.
Musk has already raised nearly $30 million for the company and could sell as much as $100 million in his own stock to fund the endeavor as well.
Now, computer implants for the brain aren't a new idea.
There are thousands of people living with Parkinson's disease right now with implants to help control their tremors.

Musk wants to take it to the next level, however — giving people with otherwise healthy brains a cybernetic edge.
Neuralink is still in its very early stages and we likely won't be able to invest in the company this year.

The Coming Age of Genetic Architects
If you really want to improve the human brain, you will have to use genetic engineering.

This is mostly illegal in the West because the Abrahamic religions (Christianity, Judaism and Islam) get very upset at the thought of creating a new not-quite-human species in the laboratory.

However, other world religions such as Hinduism (think of all those goddesses with eight arms) and Confucianism don't have this problem.

The Cognitive Research Laboratory at BGI Genomics (Shenzhen: 300676.SZ) is actively working on discovering the genetic basis of human intelligence.

It will no doubt eventually succeed and be able to produce modified human embryos with enhanced intelligence.
The potential market for this will be truly gigantic, as will the opposition.

Second Sight Medical Products Inc. (NASDAQ: EYES)
The company recently received conditional FDA approval to proceed with a cortical implant to restore vision to blind people.
https://finance.yahoo.com/news/second-sight-receives-conditional-fda-120000971.html
I believe there's little technology risk involved with these trials, as the company has already successfully implanted a less sophisticated electrode array into a patient.

So it's only a matter of Second Sight's software and advanced array restoring meaningful enough vision for patients to desire the implant.

Here's the key: After successfully demonstrating such capabilities, Second Sight's technology can be used to treat other conditions, including pain management. In other words, Second Sight's cortical implant device holds the potential to become a platform technology.

As such, the company is a natural acquisition target for Elon Musk's Neuralink. Especially since it's trading at such a low market cap of about $63 million.

Heck, a merger with the Nasdaq-listed company to get Neuralink public might unlock the "mind-blowing" gains Jonathan predicted above.
...the company deserves serious consideration...

MarketBeat.com
The Company's product, the Argus II System, treats outer retinal degenerations, such as retinitis pigmentosa (RP). The Argus II System provides an artificial form of vision that differs from the vision of people with normal sight. It does not restore normal vision and it does not slow or reverse the progression of the disease. The Company's Argus II System employs electrical stimulation to bypass degenerated photoreceptor cells and to stimulate remaining viable retinal cells thereby inducing visual perception in blind individuals. The Argus II System works by converting video images captured by a miniature camera housed in a patient's glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes that are implanted on the surface of the retina.



EYES (T/$5) bionic eye...WE Are Borg...you will be assimilated...

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.